Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT

The requested reference [300a4563d495053fe8a8728fcdc7508ad95568cd] no longer exists in our database. It has been replaced by the current reference: [cd9092a9b0f970bc735195bf9ae09f31d5ecc1c2]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
To comparing the efficacy of different durations of Maribavir treatment regimens in patients suffering from refractory CMV infection after allo-HSCT.
Epistemonikos ID: dd6ed360266f45f7097f5ec082e17720cf55f11c
First added on: Apr 07, 2026